产品介绍 FAQs 评论(0)
宿主来源
Rabbit抗原名称
IL-33分子别名
Interleukin-33; Interleukin-1 family member 11 (IL-1F11); Nuclear factor from high endothelial venules (NF-HEV); C9orf26; IL1F11; NFHEV免疫原
Recombinant Protein细胞定位
Nucleus, Secreted, CytoplasmAccession
O95760克隆号
S-1700-17抗体类型
Recombinant mAb抗体同种型
IgG反应种属 ?
Hu纯化方式
Protein A浓度
0.5 mg/ml标记
Unconjugated性状
Liquid缓冲体系
PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
储存条件
12 months from date of receipt / reconstitution, -20 °C as supplied
应用
WB
稀释度
应用 稀释度 推荐种属 WB 1:1000 Hu
IL-33 protein is a key cytokine belonging to the IL-1 family, functioning as an alarmin that plays crucial roles in tissue homeostasis, pathogenic infection, inflammation, allergy, and type 2 immunity. It is abundantly expressed in endothelial cells, epithelial cells, and fibroblast-like cells. IL-33 transmits signals through its receptor ST2, which is expressed on the surface of T helper 2 (Th2) cells and group 2 innate lymphoid cells (ILC2s), inducing transcription of Th2-associated cytokine genes and host defense against pathogens. In innate immunity, IL-33 activates ILC2s, basophils, eosinophils, and mast cells to drive early immune responses against allergens and other environmental insults. In adaptive immunity, it regulates the functions of dendritic cells (DCs) and influences the development of Th2, Tfh, and other immune cells. IL-33 is released upon cellular damage or stress and can enhance the differentiation of recently activated T cells. It is also involved in the development of multiple types of immune-related diseases, making it a promising therapeutic target for modulating immune responses in conditions such as asthma, allergic diseases, and autoimmune disorders.
免疫印迹
WB result of IL-33 Recombinant Rabbit mAb
Primary antibody: IL-33 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: untreated THP-1 whole cell lysate 20 µg
Lane 2: THP-1 treated with 50 nM TMA and 5 µg/ml LPS for 24 hours whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 31 kDa
Observed MW: 30 kDa
FAQs
我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定







评论(0)